Platinum Industries Ltd

Platinum Industries Limited has responded to a clarification request from BSE Limited regarding unusual volume movement in its equity shares. The company stated that it has consistently complied with SEBI regulations by disclosing all material events and price-sensitive information. Platinum Industries asserts that it has not withheld any information that could impact its share price or trading volume. The company attributes the recent volume fluctuations purely to market conditions and market-driven factors, assuring that no internal factors are responsible.

Platinum Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the board of directors approves the unaudited financial results for the quarter ending June 30, 2026. During this period, directors, designated employees, key managerial personnel, and their immediate relatives are prohibited from trading in the company's shares.

Platinum Industries Ltd has announced an upcoming plant visit for investors and analysts scheduled for June 25, 2026, in Palghar, Maharashtra. The company will refer to publicly available information during discussions, ensuring no confidential or unpublished price-sensitive information (UPSI) is shared. This initiative aims to provide stakeholders with direct insight into the company's operations.

Platinum Industries Ltd has announced the commencement of commercial production at its manufacturing facility located in Palghar, Maharashtra, effective May 21, 2026. This completes the setup of the facility, an objective of the company's Initial Public Offer. Partial commercial production had already begun on August 08, 2025. With the remaining facilities now operational, the manufacturing unit is fully operational, marking a significant milestone in the company's expansion.

Platinum Industries Ltd has submitted a Monitoring Agency Report by CRISIL Ratings Limited, concerning the utilization of IPO proceeds for the quarter ended March 31, 2026. The report, dated May 14, 2026, confirms that the IPO proceeds are being utilized as disclosed in the prospectus. The Audit Committee reviewed the report on May 12, 2026, and the Monitoring Agency declares no conflict of interest.

Platinum Industries Ltd has authorized key managerial personnel (KMP) to determine the materiality of events and make disclosures to stock exchanges under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The authorized KMPs include Krishna Dushyant Rana (Managing Director), Ashok Bothra (CFO), and Bhagyashree Mallawat (CS). Their contact details are provided for disclosure purposes, and this information is available on the company's website.

Platinum Industries Ltd announced a modified opinion on its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The decision was made during a Board Meeting held on May 12, 2026. Additionally, the board approved the appointment of M/s Pipalia Singhal & Associates as Internal Auditors for FY 2026-27 and approved the issuance of fresh equity shares by its subsidiary, Rivadu Lifesciences Private Limited, conditional to maintaining a minimum 51% shareholding.

Platinum Industries Ltd's board meeting on May 12, 2026, approved the audited standalone and consolidated financial results for the year ended March 31, 2026, with a modified opinion from the statutory auditors. M/s Pipalia Singhal & Associates were appointed as the internal auditors for FY 2026-27. The Senior Managerial Personnel (SMP) of the company was reconstituted. Additionally, the board approved the issuance of fresh equity shares by its subsidiary, Rivadu Lifesciences Private Limited, ensuring Platinum Industries maintains at least 51% shareholding.

Platinum Industries Ltd has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved these results in their meeting held on May 12, 2026. The auditor's report on the standalone and consolidated financial results includes a modified opinion. The board also approved the appointment of M/s Pipalia Singhal & Associates as the Internal Auditors for FY 2026-27 and approved the issuance of fresh equity shares by its subsidiary, Rivadu Lifesciences Private Limited, conditional to maintaining a minimum 51% shareholding.

Platinum Industries Ltd's board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The auditor's report on standalone and consolidated financial results is submitted with a modified opinion. The board also approved the appointment of M/s Pipalia Singhal & Associates as Internal Auditors for FY 2026-27 and re-constituted the Senior Managerial Personnel (SMP) of the Company. Additionally, the board approved the issuance of fresh equity shares by its subsidiary, Rivadu Lifesciences Private Limited, conditional to maintaining a minimum 51% shareholding.